review and approval by the Advisory Committee. In reviewing or prescribing standards and procedures as required under this subsection, the Advisory Committee shall consider standards and procedures adopted in other States with respect to the screening of congenital Cytomegalovirus, the standards and procedures adopted in such State with respect to the screening of infants for other heritable diseases, and any scientific evidence the Advisory Committee considers relevant to provide for the screening of infants for congenital Cytomegalovirus. (c) Grants (1) Health Resources and Services Administration (A) In general The Secretary, acting through the Administrator of the Health Resources and Services Administration, shall award grants to States that prescribe standards and procedures in accordance with paragraphs (1) and (2), to be distributed by the States to entities described in subsection (a) to administer tests in accordance with that subsection. (B) Authorization of appropriations There is authorized to be appropriated to carry out subparagraph (A) such sums as may be necessary for each of fiscal years 2024 and 2025. (2) Centers for disease control and prevention (A) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award grants to, or enter into cooperative agreements with, States to provide technical assistance to State agencies or designated entities of States— (i) to develop, maintain, and improve data collection systems relating to congenital Cytomegalovirus